185 related articles for article (PubMed ID: 33986027)
1. Socioeconomic biases in asthma control and specialist referral of possible severe asthma.
Håkansson KEJ; Backer V; Ulrik CS
Eur Respir J; 2021 Dec; 58(6):. PubMed ID: 33986027
[TBL] [Abstract][Full Text] [Related]
2. Impact of family socioeconomic position on childhood asthma outcomes, severity, and specialist referral - a Danish nationwide study.
Renzi-Lomholt M; Ulrik CS; Rastogi D; Stæhr Jensen JU; Håkansson KEJ
Chron Respir Dis; 2024; 21():14799731241231816. PubMed ID: 38378166
[TBL] [Abstract][Full Text] [Related]
3. Burden and unmet need for specialist care in poorly controlled and severe childhood asthma in a Danish nationwide cohort.
Håkansson KEJ; Guerrero SC; Backer V; Ulrik CS; Rastogi D
Respir Res; 2023 Jun; 24(1):173. PubMed ID: 37370052
[TBL] [Abstract][Full Text] [Related]
4. Drug utilization and asthma control among young Danish adults with asthma. Analyses of trends and determinants.
Davidsen JR
Dan Med J; 2012 Aug; 59(8):B4501. PubMed ID: 22849986
[TBL] [Abstract][Full Text] [Related]
5. Socioeconomic status is associated with healthcare seeking behaviour and disease burden in young adults with asthma - A nationwide cohort study.
Håkansson KEJ; Backer V; Ulrik CS
Chron Respir Dis; 2022; 19():14799731221117297. PubMed ID: 35938497
[TBL] [Abstract][Full Text] [Related]
6. Combination of inhaled long-acting beta2-agonists and inhaled steroids versus higher dose of inhaled steroids in children and adults with persistent asthma.
Greenstone IR; Ni Chroinin MN; Masse V; Danish A; Magdalinos H; Zhang X; Ducharme FM
Cochrane Database Syst Rev; 2005 Oct; (4):CD005533. PubMed ID: 16235409
[TBL] [Abstract][Full Text] [Related]
7. Potential Severe Asthma Hidden in UK Primary Care.
Ryan D; Heatley H; Heaney LG; Jackson DJ; Pfeffer PE; Busby J; Menzies-Gow AN; Jones R; Tran TN; Al-Ahmad M; Backer V; Belhassen M; Bosnic-Anticevich S; Bourdin A; Bulathsinhala L; Carter V; Chaudhry I; Eleangovan N; FitzGerald JM; Gibson PG; Hosseini N; Kaplan A; Murray RB; Rhee CK; Van Ganse E; Price DB
J Allergy Clin Immunol Pract; 2021 Apr; 9(4):1612-1623.e9. PubMed ID: 33309935
[TBL] [Abstract][Full Text] [Related]
8. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma.
Blanchette CM; Culler SD; Ershoff D; Gutierrez B
Clin Ther; 2009 Nov; 31(11):2574-83. PubMed ID: 20110003
[TBL] [Abstract][Full Text] [Related]
9. The prevalence of severe asthma and low asthma control among Danish adults.
von Bülow A; Kriegbaum M; Backer V; Porsbjerg C
J Allergy Clin Immunol Pract; 2014; 2(6):759-67. PubMed ID: 25439368
[TBL] [Abstract][Full Text] [Related]
10. High use of health services in patients with suboptimal asthma drug regimens: a population-based assessment in British Columbia, Canada.
Zhang T; Smith MA; Camp PG; Carleton BC
Pharmacoepidemiol Drug Saf; 2013 Jul; 22(7):744-51. PubMed ID: 23559540
[TBL] [Abstract][Full Text] [Related]
11. Impact of socioeconomic status on the use of inhaled corticosteroids in young adult asthmatics.
Davidsen JR; Søndergaard J; Hallas J; Siersted HC; Knudsen TB; Lykkegaard J; Andersen M
Respir Med; 2011 May; 105(5):683-90. PubMed ID: 21145222
[TBL] [Abstract][Full Text] [Related]
12. Long-acting muscarinic antagonists (LAMA) added to inhaled corticosteroids (ICS) versus the same dose of ICS alone for adults with asthma.
Anderson DE; Kew KM; Boyter AC
Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD011397. PubMed ID: 26301488
[TBL] [Abstract][Full Text] [Related]
13. Composite type-2 biomarker strategy versus a symptom-risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial.
Heaney LG; Busby J; Hanratty CE; Djukanovic R; Woodcock A; Walker SM; Hardman TC; Arron JR; Choy DF; Bradding P; Brightling CE; Chaudhuri R; Cowan DC; Mansur AH; Fowler SJ; Niven RM; Howarth PH; Lordan JL; Menzies-Gow A; Harrison TW; Robinson DS; Holweg CTJ; Matthews JG; Pavord ID;
Lancet Respir Med; 2021 Jan; 9(1):57-68. PubMed ID: 32916135
[TBL] [Abstract][Full Text] [Related]
14. Resource utilization in asthma: combined fluticasone propionate/salmeterol compared with inhaled corticosteroids.
Friedman HS; Yawn BP
Curr Med Res Opin; 2007 Feb; 23(2):427-34. PubMed ID: 17288696
[TBL] [Abstract][Full Text] [Related]
15. Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults.
Chauhan BF; Chartrand C; Ducharme FM
Cochrane Database Syst Rev; 2013 Feb; (2):CD009611. PubMed ID: 23450606
[TBL] [Abstract][Full Text] [Related]
16. Comparative Effectiveness of Step-up Therapies in Children with Asthma Prescribed Inhaled Corticosteroids: A Historical Cohort Study.
Murray CS; Thomas M; Richardson K; Price DB; Turner SW
J Allergy Clin Immunol Pract; 2017; 5(4):1082-1090.e7. PubMed ID: 28351789
[TBL] [Abstract][Full Text] [Related]
17. Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults.
Chauhan BF; Chartrand C; Ducharme FM
Cochrane Database Syst Rev; 2012 Dec; 12():CD009611. PubMed ID: 23235678
[TBL] [Abstract][Full Text] [Related]
18. Regular treatment with formoterol and inhaled steroids for chronic asthma: serious adverse events.
Cates CJ; Jaeschke R; Schmidt S; Ferrer M
Cochrane Database Syst Rev; 2013 Jun; (6):CD006924. PubMed ID: 23744625
[TBL] [Abstract][Full Text] [Related]
19. Early use of inhaled corticosteroids in the emergency department treatment of acute asthma.
Edmonds ML; Camargo CA; Pollack CV; Rowe BH
Cochrane Database Syst Rev; 2000; (3):CD002308. PubMed ID: 10908552
[TBL] [Abstract][Full Text] [Related]
20. Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults.
Ni CM; Greenstone IR; Ducharme FM
Cochrane Database Syst Rev; 2005 Apr; (2):CD005307. PubMed ID: 15846751
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
